Chemoinformaics analysis of 4-Sinapoyl quinic acid
| Molecular Weight | 398.364 | nRot | 6 |
| Heavy Atom Molecular Weight | 376.188 | nRig | 15 |
| Exact Molecular Weight | 398.121 | nRing | 2 |
| Solubility: LogS | -2.036 | nHRing | 0 |
| Solubility: LogP | 0.271 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 1 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 6 |
| nHA | 9 | APOL | 52.7494 |
| nHD | 5 | BPOL | 29.0146 |
| QED | 0.316 |
| Synth | 3.537 |
| Natural Product Likeliness | 1.677 |
| NR-PPAR-gamma | 0.738 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.557 |
| HIA | 0.958 |
| CACO-2 | -6.253 |
| MDCK | 0.000149295 |
| BBB | 0.867 |
| PPB | 0.385673 |
| VDSS | 0.441 |
| FU | 0.281496 |
| CYP1A2-inh | 0.045 |
| CYP1A2-sub | 0.12 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.094 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.13 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.068 |
| CL | 3.58 |
| T12 | 0.93 |
| hERG | 0.015 |
| Ames | 0.013 |
| ROA | 0.018 |
| SkinSen | 0.174 |
| Carcinogencity | 0.033 |
| EI | 0.018 |
| Respiratory | 0.025 |
| NR-Aromatase | 0.401 |
| Antiviral | Yes |
| Prediction | 0.524885 |